newsfilter
← Latest News
GlobeNewswire·

MediPharm Labs Responds to Fabricated Allegations from Dissident Shareholder

TORONTO, May 29, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX:LABS) (OTCQB:MEDIF) (FSE:MLZ) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, today confirmed